Skip to main content
Top
Published in: Journal of Neural Transmission 3/2013

01-03-2013 | Translational Neurosciences - Original Article

Lack of migraine in headaches of familial dysautonomia patients

Authors: Boris Shihman, Israel Steiner, Ivelin Yovchev, Channa Maayan

Published in: Journal of Neural Transmission | Issue 3/2013

Login to get access

Abstract

Familial Dysautonomia (FD) is an autosomal recessive genetic disease where autonomic and sensory functions are defective affecting many body systems including the vascular. Plasma level of the neurotransmitter Calcitonin Gene Related Peptide (CGRP) is decreased in FD patients. This compound has been implicated to take part in the pathogenesis of migraine. We aimed to evaluate the symptoms of headaches in FD patients and to test the hypothesis that these patients will have a low incidence of migrainous headache. Sixty-five FD patients were evaluated by a medical headache questionnaire. Mean age was 23.73 + 10.82 years (mean 21 years) and there were 37 males (57 %).Thirty-eight patients (58.5 %) described having episodic headache conforming to criteria of tension headache, and in 17 of those 38 (44.7 %) headache were dependent on changes in blood pressure, except from one patient who had complaints that matched diagnosis of acephalic migraine. None of the patients had symptoms compatible with migraine or cluster headache. Results show that the headache is a very common complaint in FD, there is lack of migraine symptoms in this group. This might be attributed to defective sensory innervation and deficiency of CGRP. FD could be regarded as a human model for CGRP deficiency when studying the pathogenesis of migraine.
Literature
go back to reference Aguayo AJ, Nair CP, Bray GM (1971) Peripheral nerve abnormalities in the Riley-Day syndrome. Findings in a sural nerve biopsy. Arch Neurol 24:106–116PubMedCrossRef Aguayo AJ, Nair CP, Bray GM (1971) Peripheral nerve abnormalities in the Riley-Day syndrome. Findings in a sural nerve biopsy. Arch Neurol 24:106–116PubMedCrossRef
go back to reference Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, Ekstein J, Rubin BY (2001) Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 68:753–758PubMedCrossRef Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, Ekstein J, Rubin BY (2001) Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 68:753–758PubMedCrossRef
go back to reference Asghar MS, Hansen AE, Kapijimpanga T, van der Geest RJ, van der Koning P, Larsson HB, Olesen J, Ashina M (2010) Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology 75:1520–1526PubMedCrossRef Asghar MS, Hansen AE, Kapijimpanga T, van der Geest RJ, van der Koning P, Larsson HB, Olesen J, Ashina M (2010) Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology 75:1520–1526PubMedCrossRef
go back to reference Axelrod FB, Goldberg JD, Ye XY, Maayan C (2002) Survival in familial dysautonomia: impact of early intervention. J Pediatr 141:518–523PubMedCrossRef Axelrod FB, Goldberg JD, Ye XY, Maayan C (2002) Survival in familial dysautonomia: impact of early intervention. J Pediatr 141:518–523PubMedCrossRef
go back to reference Benemei S, Nicoletti P, Capone JA, Geppetti P (2007) Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol Sci 28(Suppl 2):S89–S93PubMedCrossRef Benemei S, Nicoletti P, Capone JA, Geppetti P (2007) Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol Sci 28(Suppl 2):S89–S93PubMedCrossRef
go back to reference Doods H, Arndt K, Rudolf K, Just S (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580–587PubMedCrossRef Doods H, Arndt K, Rudolf K, Just S (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580–587PubMedCrossRef
go back to reference Edvisson I, Ho TW (2010) CGRP receptor antagonism and migraine. Neurotherapeutics 7:164–175CrossRef Edvisson I, Ho TW (2010) CGRP receptor antagonism and migraine. Neurotherapeutics 7:164–175CrossRef
go back to reference Gold-von Simson G, Axelrod FB (2006) Familial dysautonomia: update and recent advances. Curr Probl Pediatr Adolesc Health Care 36:218–237PubMedCrossRef Gold-von Simson G, Axelrod FB (2006) Familial dysautonomia: update and recent advances. Curr Probl Pediatr Adolesc Health Care 36:218–237PubMedCrossRef
go back to reference Grover-Johnson N, Pearson J (1976) Deficient vascular innervation in familial dysautonomia, an explanation for vascular instability. Neuropathol Appl Neurobiology 2:217–224CrossRef Grover-Johnson N, Pearson J (1976) Deficient vascular innervation in familial dysautonomia, an explanation for vascular instability. Neuropathol Appl Neurobiology 2:217–224CrossRef
go back to reference Hansen JM, Hauge AW, Olesen J, Ashina M (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30:1179–1186PubMedCrossRef Hansen JM, Hauge AW, Olesen J, Ashina M (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30:1179–1186PubMedCrossRef
go back to reference Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders 2nd edition. Cephalalgia 24(Suppl 1):9–160 Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders 2nd edition. Cephalalgia 24(Suppl 1):9–160
go back to reference Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner K (2008) Efficacy and tolerability of MK-9074 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. Lancet 372:2115–2123PubMedCrossRef Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner K (2008) Efficacy and tolerability of MK-9074 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. Lancet 372:2115–2123PubMedCrossRef
go back to reference Jang MU, Park JW, Kho HS, Chung SC, Chung JW (2011) Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis 17:187–193PubMedCrossRef Jang MU, Park JW, Kho HS, Chung SC, Chung JW (2011) Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis 17:187–193PubMedCrossRef
go back to reference Jansen-Olesen J, Mortensen A, Edvinsson I (1996) Calcitonon gene-related peptide is released from capsaicin-sensitive nerve fibers and induces vasodilation of human cerebral arteries concomitant with activation of adnyl cyclase. Cepahalalgia 16:310–316CrossRef Jansen-Olesen J, Mortensen A, Edvinsson I (1996) Calcitonon gene-related peptide is released from capsaicin-sensitive nerve fibers and induces vasodilation of human cerebral arteries concomitant with activation of adnyl cyclase. Cepahalalgia 16:310–316CrossRef
go back to reference Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalagia 22:54–61CrossRef Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalagia 22:54–61CrossRef
go back to reference Maayan C, Kaplan E, Shachar S, Godfrey S (1987) Incidence of familial dysautonomia in Israel 1977–1981. Clin Genet 32:106–108PubMedCrossRef Maayan C, Kaplan E, Shachar S, Godfrey S (1987) Incidence of familial dysautonomia in Israel 1977–1981. Clin Genet 32:106–108PubMedCrossRef
go back to reference Maayan C, Becker Y, Gesundheit B, Girgis SI (2001) Calcitonin gene related peptide in familial dysautonomia. Neuropeptides 35:189–195PubMedCrossRef Maayan C, Becker Y, Gesundheit B, Girgis SI (2001) Calcitonin gene related peptide in familial dysautonomia. Neuropeptides 35:189–195PubMedCrossRef
go back to reference Olesen J, Diener HC, Hussted IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM, BIBN 4096 BS Clinical Proof of Concept Study Group (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Eng J Med 350:1104–1110CrossRef Olesen J, Diener HC, Hussted IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM, BIBN 4096 BS Clinical Proof of Concept Study Group (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Eng J Med 350:1104–1110CrossRef
go back to reference Pearson J, Pytel BA (1978a) Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci 39:47–59PubMedCrossRef Pearson J, Pytel BA (1978a) Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci 39:47–59PubMedCrossRef
go back to reference Pearson J, Pytel BA (1978b) Quantitative studies of ciliary and sphenopalatine ganglia in familial dysautonomia. J Neurol Sci 39:123–130PubMedCrossRef Pearson J, Pytel BA (1978b) Quantitative studies of ciliary and sphenopalatine ganglia in familial dysautonomia. J Neurol Sci 39:123–130PubMedCrossRef
go back to reference Pearson J, Pytel BA, Grover-Johnson N, Axelrod F, Dancis J (1978) Quantitative studies of dorsal root ganglia and and neuropathologica observations on spinal cords in familial dysautonomia. J Neurol Sci 35:77–92PubMedCrossRef Pearson J, Pytel BA, Grover-Johnson N, Axelrod F, Dancis J (1978) Quantitative studies of dorsal root ganglia and and neuropathologica observations on spinal cords in familial dysautonomia. J Neurol Sci 35:77–92PubMedCrossRef
go back to reference Rapoport AM (2010) New acute treatments for headache. Neurol Sci 31(Suppl 1):129–132CrossRef Rapoport AM (2010) New acute treatments for headache. Neurol Sci 31(Suppl 1):129–132CrossRef
go back to reference Recober A, Russo AF (2009) Calcitonin gene-related peptide: an update on the biology. Curr Opin Neurol 22:241–246PubMedCrossRef Recober A, Russo AF (2009) Calcitonin gene-related peptide: an update on the biology. Curr Opin Neurol 22:241–246PubMedCrossRef
go back to reference Russo AF, Kuburas A, Kaiser EA, Raddant AC, Recober AA (2009) Potential Preclinical Migraine Model: CGRP-Sensitized Mice. Mol Cell Pharmacol 1:264–270PubMed Russo AF, Kuburas A, Kaiser EA, Raddant AC, Recober AA (2009) Potential Preclinical Migraine Model: CGRP-Sensitized Mice. Mol Cell Pharmacol 1:264–270PubMed
go back to reference Slaugenhaupt SA, Blumenfeld A, Gill SP et al (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598–605PubMedCrossRef Slaugenhaupt SA, Blumenfeld A, Gill SP et al (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598–605PubMedCrossRef
go back to reference Sprenger T, Goadsby PJ (2009) Migraine pathogenesis and state of pharmacological treatment options. BMC Med 7:71PubMedCrossRef Sprenger T, Goadsby PJ (2009) Migraine pathogenesis and state of pharmacological treatment options. BMC Med 7:71PubMedCrossRef
go back to reference Stewart WF, Staffa J, Lipton RB, Ottman R (1997) Familial risk of migraine: a population-based study. Ann Neurol 41:166–172PubMedCrossRef Stewart WF, Staffa J, Lipton RB, Ottman R (1997) Familial risk of migraine: a population-based study. Ann Neurol 41:166–172PubMedCrossRef
Metadata
Title
Lack of migraine in headaches of familial dysautonomia patients
Authors
Boris Shihman
Israel Steiner
Ivelin Yovchev
Channa Maayan
Publication date
01-03-2013
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 3/2013
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-012-0903-y

Other articles of this Issue 3/2013

Journal of Neural Transmission 3/2013 Go to the issue

Neurology and Preclinical Neurological Studies - Original Article

MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome

Neurology and Preclinical Neurological Studies - Original Article

Levodopa changes brain motor network function during ankle movements in Parkinson’s disease